TNFRSF13C 抗体
(Tumor Necrosis Factor Receptor Superfamily, Member 13C (TNFRSF13C))
B cell-activating factor (BAFF) enhances B-cell survival in vitro and is a regulator of the peripheral B-cell population. Overexpression of Baff in mice results in mature B-cell hyperplasia and symptoms of systemic lupus erythematosus (SLE). Also, some SLE patients have increased levels of BAFF in serum. Therefore, it has been proposed that abnormally high levels of BAFF may contribute to the pathogenesis of autoimmune diseases by enhancing the survival of autoreactive B cells. The protein encoded by this gene is a receptor for BAFF and is a type III transmembrane protein containing a single extracellular cysteine-rich domain. It is thought that this receptor is the principal receptor required for BAFF-mediated mature B-cell survival. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| TNFRSF13C 抗体 (AA 1-78) | 人, 大鼠 | 小鼠 Monoclonal |
|
|
|
| TNFRSF13C 抗体 (AA 1-78) | 人 | 小鼠 Monoclonal |
|
|
|
| TNFRSF13C 抗体 (AA 96-184) | 人 | 兔 Polyclonal |
|
|
|
| TNFRSF13C 抗体 (AA 21-169) | 大鼠 | 兔 Polyclonal |
|
|
|
| TNFRSF13C 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| TNFRSF13C 抗体 (FITC) | 人 | 小鼠 Monoclonal |
|
|
|
| TNFRSF13C 抗体 (PE) | 人 | 小鼠 Monoclonal |
|
|
|
| TNFRSF13C 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| TNFRSF13C 抗体 (AA 1-184) | 人 | 兔 Polyclonal |
|
|
|
| TNFRSF13C 抗体 (AA 7-71) | 人 | 兔 Monoclonal |
|
|
|
| TNFRSF13C 抗体 (AA 121-184) | 人 | 兔 Polyclonal |
|
|
|
| TNFRSF13C 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| TNFRSF13C 抗体 (AA 1-80) | 人 | 兔 Polyclonal |
|
|
|
| TNFRSF13C 抗体 (Biotin) | 小鼠 | 大鼠 Monoclonal |
|
|
|
| TNFRSF13C 抗体 | 小鼠 | 大鼠 Monoclonal |
|
|
|
| TNFRSF13C 抗体 (APC) | 人 | 小鼠 Monoclonal |
|
|
|
| TNFRSF13C 抗体 (AA 7-128) | 小鸡 | 兔 Polyclonal |
|
|
|
| TNFRSF13C 抗体 (AA 1-184) | 人 | 小鼠 Polyclonal |
|
|
|
| TNFRSF13C 抗体 (AA 7-71) | 人 | 兔 Monoclonal |
|
|
|
| TNFRSF13C 抗体 (AA 45-169) | 大鼠 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- ELISA (ELISA: 有验证图片)
- 适用
- 人, 大鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 5A9B6
- 标记
- unconjugated
- 抗体亚型
- IgG2b
- 抗原表位
- AA 1-78
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- ELISA (ELISA: 有验证图片)
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 5A9B10
- 标记
- unconjugated
- 抗体亚型
- IgG2b
- 抗原表位
- AA 1-78
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 有验证图片)
- ICC (Immunocytochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 96-184
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 21-169
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 11C1
- 标记
- unconjugated
- 抗体亚型
- IgG1, kappa
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 11C1
- 标记
- FITC
- 抗体亚型
- IgG1, kappa
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 11C1
- 标记
- PE
- 抗体亚型
- IgG1, kappa
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- SDS (SDS-PAGE: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- BAFFR-1557
- 标记
- unconjugated
- 抗体亚型
- IgG1, kappa
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-184
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- ELISA (ELISA: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- DM143
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 7-71
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- FACS (Flow Cytometry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 121-184
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB34078
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 1-30, N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-80
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- Func (Functional Studies: 所列应用)
1 reference - 适用
- 小鼠
- 宿主
- 大鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 9B9
- 标记
- Biotin
- 抗体亚型
- IgG2b
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- Func (Functional Studies: 所列应用)
- 适用
- 小鼠
- 宿主
- 大鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 9B9
- 标记
- unconjugated
- 抗体亚型
- IgG2b
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 11C1
- 标记
- APC
- 抗体亚型
- IgG1, kappa
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- 适用
- 小鸡
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 7-128
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-184
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- DM127
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 7-71
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 有验证图片)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 45-169
Latest Publications for our TNFRSF13C 抗体
: "Characterization of B cells in lupus erythematosus skin biopsies in the context of different immune cell infiltration patterns." in: Frontiers in medicine, Vol. 9, pp. 1037408, (2022) (PubMed).
: "B-Lymphocyte Phenotype Determines T-Lymphocyte Subset Differentiation in Autoimmune Diabetes." in: Frontiers in immunology, Vol. 10, pp. 1732, (2019) (PubMed).
: "B cell activating factor (BAFF) selects IL-10(-)B cells over IL-10(+)B cells during inflammatory responses." in: Molecular immunology, Vol. 85, pp. 18-26, (2017) (PubMed).
: "The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells." in: Leukemia, Vol. 30, Issue 1, pp. 163-72, (2016) (PubMed).
: "Human B cells induce dendritic cell maturation and favour Th2 polarization by inducing OX-40 ligand." in: Nature communications, Vol. 5, pp. 4092, (2014) (PubMed).
: "BAFF-R expression correlates with positive selection of immature B cells." in: European journal of immunology, Vol. 42, Issue 1, pp. 206-16, (2012) (PubMed).
: "APRIL binding to BCMA activates a JNK2-FOXO3-GADD45 pathway and induces a G2/M cell growth arrest in liver cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 189, Issue 10, pp. 4748-58, (2012) (PubMed).
: "BAFF levels are increased in lesional skin and sera in patients with cutaneous T-cell lymphoma." in: The British journal of dermatology, Vol. 167, Issue 2, pp. 359-67, (2012) (PubMed).
: "Fusion toxin BLyS-gelonin inhibits growth of malignant human B cell lines in vitro and in vivo." in: PLoS ONE, Vol. 7, Issue 10, pp. e47361, (2012) (PubMed).
: "Requirement for BAFF and APRIL during B cell development in GALT." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 184, Issue 10, pp. 5527-36, (2010) (PubMed).
: "B-Lymphocyte Phenotype Determines T-Lymphocyte Subset Differentiation in Autoimmune Diabetes." in: Frontiers in immunology, Vol. 10, pp. 1732, (2019) (PubMed).
: "B cell activating factor (BAFF) selects IL-10(-)B cells over IL-10(+)B cells during inflammatory responses." in: Molecular immunology, Vol. 85, pp. 18-26, (2017) (PubMed).
: "The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells." in: Leukemia, Vol. 30, Issue 1, pp. 163-72, (2016) (PubMed).
: "Human B cells induce dendritic cell maturation and favour Th2 polarization by inducing OX-40 ligand." in: Nature communications, Vol. 5, pp. 4092, (2014) (PubMed).
: "BAFF-R expression correlates with positive selection of immature B cells." in: European journal of immunology, Vol. 42, Issue 1, pp. 206-16, (2012) (PubMed).
: "APRIL binding to BCMA activates a JNK2-FOXO3-GADD45 pathway and induces a G2/M cell growth arrest in liver cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 189, Issue 10, pp. 4748-58, (2012) (PubMed).
: "BAFF levels are increased in lesional skin and sera in patients with cutaneous T-cell lymphoma." in: The British journal of dermatology, Vol. 167, Issue 2, pp. 359-67, (2012) (PubMed).
: "Fusion toxin BLyS-gelonin inhibits growth of malignant human B cell lines in vitro and in vivo." in: PLoS ONE, Vol. 7, Issue 10, pp. e47361, (2012) (PubMed).
: "Requirement for BAFF and APRIL during B cell development in GALT." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 184, Issue 10, pp. 5527-36, (2010) (PubMed).
Aliases for TNFRSF13C 抗体
TNF receptor superfamily member 13C (TNFRSF13C) 抗体TNF receptor superfamily member 13C (Tnfrsf13c) 抗体
uncharacterized LOC746611 (LOC746611) 抗体
tumor necrosis factor receptor superfamily, member 13c (Tnfrsf13c) 抗体
2010006P15Rik 抗体
BAFF-R 抗体
BAFFR 抗体
Baffr 抗体
Bcmd 抗体
Bcmd-1 抗体
Bcmd1 抗体
BROMIX 抗体
CD268 抗体
CVID4 抗体
Lvis22 抗体
prolixin 抗体
RGD1560810 抗体
TNFRSF13C 抗体
您还需要查找其他产品吗？
You are here:
